biotech

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special note of a few, which were making some major, bordering on ludicrous, claims…

IndieBio’s SF incubator lineup is making some wild biotech promises

Featured Article

Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments

Reshape has developed a robotic imaging system replete with software and AI models to help scientists track visual changes from Petri dishes and similar plate formats.

4:32 am PDT • April 9, 2024
Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments

With the news that “mini organs” have been grown for the first time using human stem cells, this futuristic area of bio-medicine is clearly accelerating by leaps and bounds. However,…

This Swedish startup wants to reduce the cost, and controversy, around stem cell production

There’s a new generative AI startup based in Paris. But what makes Bioptimus interesting is that it plans to apply everything we’ve collectively learned about AI models over the past…

Bioptimus raises $35 million seed round to develop AI foundational model focused on biology

Biotech and AI startup Cradle is finding success with its generative approach to protein design, landing big customers and a hefty $24 million of new investment. The company exited stealth…

Cradle’s AI-powered protein programming platform levels up with $24M in new funding

This pitch deck makes for some really interesting reading and storytelling, so let’s dive in and see if we can spot what happened and how.

Pitch Deck Teardown: Aether’s $49M Series A deck

Reed Jobs’ new venture firm can change the lives of the estimated 18.1 million diagnosed cancer patients worldwide. Yosemite, Jobs’ fund for cancer-fighting biotech, launched in August with $200 million…

How Reed Jobs’ venture firm tackles cancer

There’s a gold rush on in biotech as AI and other tools are used to find new drugs and treatments. With $5.5 million in new funding, Scala Biodesign is focusing…

Scala Biodesign makes it easy to re-engineer proteins one molecule at a time – or 50

Startups are so full of shit right now.  The pipes are jammed and there are so many companies that are full to bursting with the desire to un-pack them.  We’ve…

I’ve never seen so many crap startups

How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look.

11 investors predict a colorful, if difficult, future for psychedelic startups

While generative AI is buzzy right now, what OpenAI, Microsoft and Google are doing may be only part of the story. There is also the process of using biology: the…

Cortical Labs raises $10M for its Pong-playing stem cells that eventually could power AI

A brown macroalgae native to the Atlantic’s Sargasso Sea is increasingly a menace to coastal ecosystems and communities across the Gulf of Mexico, ever since mats of the normally beneficial…

Startup says the seaweed blobbing toward Florida has a silver lining

When you think of life sciences and biotech hubs in the U.S., where do you travel to in your mind? Boston? The Bay Area? Texas? Portal Innovations, a biotech VC…

This VC built a lab to make building biotech startups easier

To ensure survival, it’s essential to explore alternative funding methods rather than relying solely on classic fundraising.

5 strategies for biotech startups to outlast a market downturn

Adding predictive LTV to your startup’s marketing strategy may literally help you stop throwing money away.

TechCrunch+ roundup: Using predictive LTV, Boston VC survey, active learning for ML teams

While not totally immune to 2022’s market correction, biotech fundraising proved to be more resilient than other sectors.

Biotech proved a surprisingly bright spot in 2022’s startup correction

“Growth at all costs” is a fairy tale made possible by cheap money that helped VCs set expectations for founders — and each other.

TechCrunch+ roundup: New VC rules, AI biotech investor survey, Instagram ad case study

On the heels of the Biden administration’s decision to impose sweeping chip sanctions on China, there are signs that China might also lose access to other types of critical U.S.…

US sanctions on China could extend to biotech, official says

Fermentation has a long, rich history in food production, from beer and wine to yogurt and cheese, leavened bread and coffee, miso and tempeh, sauerkraut and kimchi, to name just…

Solar Foods wants to replace industrial animal farming with a high-tech protein harvest

Healthcare startups often face unique challenges — something Well Health founder Guillaume de Zwirek understands. Together with Freestyle Partner, Jenny Lefcourt, the two will speak on the strategies used by…

Breaking into healthcare with WELL Health and Freestyle on TechCrunch Live

Based in Japan, biotech startup Dioseve’s ambitious goal is to grow human oocytes, or eggs, from other tissue. Its aim is to help people struggling with infertility, and it recently…

Dioseve wants to help infertile people with tech that grows egg cells

If you’ve ever had the misfortune of needing continuous EKG monitoring, you’ve probably used a Holter monitor. It’s like carrying a 1980s walkman made of metal with a bunch of…

Mawi launches a patch to track your heart health faster and in real time

Hello, friends, and welcome to Daily Crunch, bringing you the most important startup, tech and venture capital news in a single package.

Daily Crunch: Raba Partnership leads $2.1M seed round for African fintech startup Thepeer

Many of us take prescription medication with little to no understanding of just how long it takes — or how much it costs — to get that drug to market.…

Auxilius lands $10M to help biopharmas manage financial aspects of the clinical trial process

Felix Williams is the founder and managing director of Lagomaj Capital. Since starting the St. Louis, Missouri-based venture capital firm soon after completing high school, 23-year-old Williams has backed dozens…

Why Felix Williams, who started a VC firm at 19, believes his youth gives him an advantage as an investor

Bacterial secretions might dye your future wardrobe, and that’d be an improvement. That’s because textiles usually get their hues from toxic chemicals, and the resulting wastewater — laden with dyes,…

Steal this hot new summer look (it’s bacteria)

Humble Bee Bio is on a mission to create a biodegradable alternative to plastics by synthesizing the biology of bees. While the New Zealand-based company is still at an early…

New Zealand’s Humble Bee Bio is using bees to create bioplastics

Cultivated meat, grown in a bioreactor rather than out on the range, might be one of the big food trends of the decade. But it’s relying on tech built around…

Unicorn Bio is building the hardware to scale cultivated meat from lab to table

The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and…

Automata expands its lab automation ambitions with $50M B round

Tech is an increasingly important part of the complex drug discovery and testing process, and with advances in processing power and algorithms it is tapping new areas for analysis. Proteomics,…

With $8M seed round, Protai leverages the proteome to speed up drug discovery